Randomized Trial of Liraglutide and Insulin Therapy on Hepatic Steatosis as Measured by MRI and MRS in Metformin-treated Patients With Type 2 Diabetes: an Open Pilot Study.

Trial Profile

Randomized Trial of Liraglutide and Insulin Therapy on Hepatic Steatosis as Measured by MRI and MRS in Metformin-treated Patients With Type 2 Diabetes: an Open Pilot Study.

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Nov 2015

At a glance

  • Drugs Insulin glargine (Primary) ; Liraglutide (Primary) ; Metformin
  • Indications Fatty liver; Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms LIRAINS
  • Most Recent Events

    • 25 Feb 2013 Planned End Date changed from 1 Dec 2012 to 1 Dec 2014as reported by ClinicalTrials.gov.
    • 26 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top